Barclays »

Prime Medicine shares owned by Barclays

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $480k 54k 8.85
2023-09-30 $621k 65k 9.53
2023-06-30 $116k 7.9k 14.72
2023-03-31 $65k 5.3k 12.18
2022-12-31 $52k 2.8k 18.66